AU2013369473B2 - Process for the preparation of 1-((1,3)dioxolan-4-ylmethyl)-1h-pyrazol-3-ylamine - Google Patents
Process for the preparation of 1-((1,3)dioxolan-4-ylmethyl)-1h-pyrazol-3-ylamine Download PDFInfo
- Publication number
- AU2013369473B2 AU2013369473B2 AU2013369473A AU2013369473A AU2013369473B2 AU 2013369473 B2 AU2013369473 B2 AU 2013369473B2 AU 2013369473 A AU2013369473 A AU 2013369473A AU 2013369473 A AU2013369473 A AU 2013369473A AU 2013369473 B2 AU2013369473 B2 AU 2013369473B2
- Authority
- AU
- Australia
- Prior art keywords
- process according
- formula
- compound
- anyone
- reaction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/38—Nitrogen atoms
- C07D231/40—Acylated on said nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNPCT/CN2012/087380 | 2012-12-25 | ||
| CN2012087380 | 2012-12-25 | ||
| PCT/EP2013/077563 WO2014102164A1 (en) | 2012-12-25 | 2013-12-20 | Process for the preparation of 1-([1,3]dioxolan-4-ylmethyl)-1h-pyrazol-3-ylamine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2013369473A1 AU2013369473A1 (en) | 2015-07-16 |
| AU2013369473B2 true AU2013369473B2 (en) | 2017-03-09 |
Family
ID=49876646
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2013369473A Active AU2013369473B2 (en) | 2012-12-25 | 2013-12-20 | Process for the preparation of 1-((1,3)dioxolan-4-ylmethyl)-1h-pyrazol-3-ylamine |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US9388168B2 (enExample) |
| EP (1) | EP2938609B1 (enExample) |
| JP (1) | JP6297590B2 (enExample) |
| KR (1) | KR102122569B1 (enExample) |
| CN (1) | CN105051031B (enExample) |
| AU (1) | AU2013369473B2 (enExample) |
| BR (1) | BR112015015229B1 (enExample) |
| CA (1) | CA2896155C (enExample) |
| CY (1) | CY1119040T1 (enExample) |
| DK (1) | DK2938609T3 (enExample) |
| ES (1) | ES2629313T3 (enExample) |
| HR (1) | HRP20170653T1 (enExample) |
| HU (1) | HUE032621T2 (enExample) |
| IL (1) | IL239558A (enExample) |
| LT (1) | LT2938609T (enExample) |
| NZ (1) | NZ709362A (enExample) |
| PL (1) | PL2938609T3 (enExample) |
| PT (1) | PT2938609T (enExample) |
| RU (1) | RU2621725C2 (enExample) |
| SG (1) | SG11201504951TA (enExample) |
| SI (1) | SI2938609T1 (enExample) |
| WO (1) | WO2014102164A1 (enExample) |
| ZA (1) | ZA201504601B (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11266630B2 (en) * | 2016-12-15 | 2022-03-08 | Hua Medicine (Shanghai) Ltd. | Oral preparation of glucokinase activator and preparation method therefor |
| CN113493442B (zh) * | 2020-04-03 | 2024-11-08 | 天津药物研究院有限公司 | 作为葡萄糖激酶活化剂的吡咯烷酮衍生物及其制备方法和用途 |
| US11813274B2 (en) | 2020-04-22 | 2023-11-14 | Hua Medicine (Shanghai) Ltd. | Treating untreated or treatment-resistant diabetes with glucokinase activator and sodium-glucose cotransporter-2 inhibitor |
| WO2021212360A1 (en) * | 2020-04-22 | 2021-10-28 | Hua Medicine (Shanghai) Ltd. | Treating untreated or treatment-resistant diabetes with glucokinase activator and sodium-glucose cotransporter-2 inhibitor |
| CN111732543A (zh) * | 2020-08-14 | 2020-10-02 | 浙江鼎龙科技有限公司 | 一种4,5-二氨基-1-（2-羟乙基）吡唑硫酸盐的制备方法 |
| CN113750100B (zh) * | 2021-08-31 | 2022-12-30 | 海南中济医药科技有限公司 | 一种含有多扎格列艾汀与西格列汀的药物组合物及其制备方法 |
| AR127064A1 (es) * | 2021-09-15 | 2023-12-13 | Hua Medicine Shanghai Ltd | Prodroga de derivados de pirrolidona como activador de glucoquinasa |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009127546A1 (en) * | 2008-04-16 | 2009-10-22 | F. Hoffmann-La Roche Ag | Pyrrolidinone glucokinase activators |
| EP2236498A1 (en) * | 2008-01-18 | 2010-10-06 | Astellas Pharma Inc. | Phenyl acetamide derivative |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4160841A (en) * | 1977-01-31 | 1979-07-10 | Janssen Pharmaceutica, N.V. | Heterocyclic derivatives of 1-(1,3-dioxolan-2-ylmethyl)-1H-imidazoles |
| FR2748274B1 (fr) * | 1996-05-03 | 1998-06-12 | Oreal | Nouveaux diamino pyrazoles, leur synthese, compositions de teinture des fibres keratiniques les contenant, procede de teinture des fibres keratiniques |
| US8178689B2 (en) * | 2010-06-17 | 2012-05-15 | Hoffman-La Roche Inc. | Tricyclic compounds |
-
2013
- 2013-12-20 HU HUE13811542A patent/HUE032621T2/en unknown
- 2013-12-20 SI SI201330684A patent/SI2938609T1/sl unknown
- 2013-12-20 AU AU2013369473A patent/AU2013369473B2/en active Active
- 2013-12-20 NZ NZ709362A patent/NZ709362A/en unknown
- 2013-12-20 CN CN201380068179.8A patent/CN105051031B/zh active Active
- 2013-12-20 PT PT138115423T patent/PT2938609T/pt unknown
- 2013-12-20 ES ES13811542.3T patent/ES2629313T3/es active Active
- 2013-12-20 KR KR1020157019691A patent/KR102122569B1/ko active Active
- 2013-12-20 US US14/655,287 patent/US9388168B2/en active Active
- 2013-12-20 JP JP2015550041A patent/JP6297590B2/ja active Active
- 2013-12-20 DK DK13811542.3T patent/DK2938609T3/en active
- 2013-12-20 RU RU2015126911A patent/RU2621725C2/ru active
- 2013-12-20 PL PL13811542T patent/PL2938609T3/pl unknown
- 2013-12-20 LT LTEP13811542.3T patent/LT2938609T/lt unknown
- 2013-12-20 SG SG11201504951TA patent/SG11201504951TA/en unknown
- 2013-12-20 BR BR112015015229-5A patent/BR112015015229B1/pt active IP Right Grant
- 2013-12-20 HR HRP20170653TT patent/HRP20170653T1/hr unknown
- 2013-12-20 CA CA2896155A patent/CA2896155C/en active Active
- 2013-12-20 WO PCT/EP2013/077563 patent/WO2014102164A1/en not_active Ceased
- 2013-12-20 EP EP13811542.3A patent/EP2938609B1/en active Active
-
2015
- 2015-06-21 IL IL239558A patent/IL239558A/en active IP Right Grant
- 2015-06-25 ZA ZA2015/04601A patent/ZA201504601B/en unknown
-
2017
- 2017-07-10 CY CY20171100727T patent/CY1119040T1/el unknown
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2236498A1 (en) * | 2008-01-18 | 2010-10-06 | Astellas Pharma Inc. | Phenyl acetamide derivative |
| WO2009127546A1 (en) * | 2008-04-16 | 2009-10-22 | F. Hoffmann-La Roche Ag | Pyrrolidinone glucokinase activators |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2013369473B2 (en) | Process for the preparation of 1-((1,3)dioxolan-4-ylmethyl)-1h-pyrazol-3-ylamine | |
| US20200039937A1 (en) | Process for the preparation of a 2-pyridylethylcarboxamide derivative | |
| IL271974B (en) | Novel intermediates useful for the synthesis of aminopyrimidine derivatives, process for preparing the same, and process for preparing aminopyrimidine derivatives using the same | |
| US9828340B2 (en) | Asymmetric synthesis of a substituted pyrrolidine-2-carboxamide | |
| JP2682705B2 (ja) | ２，６−ジクロロフェニルアミノベンゼン酢酸誘導体及びジフェニルアミン誘導体の製造方法。 | |
| EP2486012B1 (en) | Processes for the preparation of 2-(1-phenylethyl) isoindolin-1-one compounds | |
| US6573384B1 (en) | Process for production of indole derivatives and intermediates therefor | |
| JP7702969B2 (ja) | アルキル７－アミノ－５－メチル－［１，２，５］オキサジアゾロ［３，４－ｂ］ピリジンカルボキシレートの連続製造方法 | |
| CN116987112B (en) | Improved process for preparing aminopyrimidine derivatives | |
| HK1213262B (en) | Process for the preparation of 1-([1,3]dioxolan-4-ylmethyl)-1h-pyrazol-3-ylamine | |
| JP2003246779A (ja) | ４，５−ジアルコキシカルボニル又は４，５−ジシアノイミダゾールの製造方法 | |
| JPH072809A (ja) | アミノチアゾール酢酸誘導体の新規製造法 | |
| JP2013035854A (ja) | テトラヒドロピラン化合物の製造方法 | |
| JPH11152282A (ja) | 新規なカルボン酸誘導体およびその製造方法 | |
| WO2010026918A1 (ja) | α－トリフルオロメチル－β－置換－β－アミノ酸類の製造方法 | |
| JP2000327652A (ja) | フタロニトリル誘導体およびその製造方法 | |
| CN116987112A (zh) | 制备氨基嘧啶衍生物的改善方法 | |
| HK40027082A (en) | Novel intermediates useful for the synthesis of aminopyrimidine derivatives, process for preparing the same, and process for preparing aminopyrimidine derivatives using the same | |
| EP2796455A1 (en) | Method for producing sulfonate | |
| JP2002080461A (ja) | ５−（２−置換−４−ニトロフェニル）−オキサゾールの製造方法 | |
| HK1168596B (en) | Processes for the preparation of 2-(1-phenylethyl) isoindolin-1-one compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) | ||
| PC | Assignment registered |
Owner name: HUA MEDICINE (SHANGHAI) LTD. Free format text: FORMER OWNER(S): HUA MEDICINE |